Journal of Drugs in Dermatology

View more issues:

Articles in March-April, 2004 issue of Journal of Drugs in Dermatology

• Cutaneous ulcerative lichen planus exhibiting pathergy, response to acitretin
  by Robert L. Henderson, Jr.
• Safety, efficacy and pharmacokinetics of an antibody for psoriatic arthritis
• Topical retinoid and antibiotic combination therapy for acne management
  by Jonathan S. Weiss
• Delayed type hypersensitivity to benzoyl peroxide
  by Christina Shwereb
• Ertaczo approved by FDA for athlete's foot
• Previously unpublished case reports and case studies are eligible for this open-ended contest
• Editorialism in the December 2003 issue
• Bilateral facial apocrine chromhidrosis
  by Benjamin Barankin
• Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme
• High-dose combination chemotherapy plus peripheral stem cell transplantation in treating patients with advanced cancer
• Conditioning, the placebo effect, and psoriasis
• The acquisition of blood and skin samples from normal volunteers to support research activities on dermatologic diseases
• Oral tazarotene and oral pimecrolimus: novel oral therapies in development for psoriasis
  by Fiza Singh
• Keratoacanthoma arising from an excisional surgery scar
  by Arash Kimyai-Asadi
• Tularik begins Phase II trial of T487 in psoriasis
• Photodynamic therapy in treating patients with skin cancer or solid tumors metastatic to the skin
• Evaluation and treatment of patients with dermatologic diseases
• Etanercept as monotherapy in patients with psoriasis
• Oral acyclovir for neonatal HSV disease of the skin, eyes, and mouth
• An immunologic mechanism for the therapeutic efficacy of minoxidil in alopecia areata
  by M.R. Namazi
• Myths of isotretinoin therapy in patients with acne: a personal opinion
  by Joseph Alcalay
• NicOx and Biolipox pharmaceuticals enter Phase II trials for NCX 1510
• Topical PTH is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial
• Peripheral stem cell transplantation plus monoclonal antibody therapy in treating patients with high-risk hematologic cancer, refractory breast or kidney cancer, or melanoma
• Preliminary study of safety and efficacy of nanocrystalline silver cream in atopic dermatitis
• Errata
• The successful use of ALA-PDT in the treatment of recalcitrant molluscum contagiosum
  by Michael H. Gold
• Once-daily Sebazole effective in treating seborrheic dermatitis
• Successful treatment of recalcitrant palmoplantar psoriasis with etanercept
• Characterizing serum protein patterns in selected skin diseases
• BCX-1777 in treating patients with refractory cancer
• Examination of clinical and laboratory abnormalities in patients with defective DNA repair: xeroderma pigmentosum, Cockayne syndrome, or trichothiodystrophy
• Continuing care and treatment for patients with cancer/AIDS/skin disease
• Hyaluronic acid filler Restylane approved by the FDA
• Seborrheic dermatitis of the scalp: etiology and treatment
  by Aditya K. Gupta
• Treatment of Hailey-Hailey disease with tacrolimus ointment and clobetasol propionate foam
  by Saleem A. Umar
• La Jolla Pharmaceuticals files NDA for lupus drug
• Cancer risk in carriers of the gene for xeroderma pigmentosum
• Current concepts in the management of actinic keratosis
• Novel peptide enters Phase II trial in the treatment of acne
• Veni, VD, Vici: twelve points about herpes that need to be conquered
  by Craig G. Burkhart
• The Miami special: a simple tool for quality section mounting in Mohs surgery
  by Keyvan Nouri
• Icatibant shows positive results in Phase II studies in the treatment of hereditary angioedema
• Structure of the herpes simplex virus receptor
• Botulinum toxin type a: fine-tuning treatment of facial nerve injury
  by J. Charlie Finn
• Atrisone, 5% topical dapsone, completes Phase III studies
• Topical tacrolimus treatment for cicatricial pemphigoid
• Evaluating the antitumor activity of MEDI-522 with or without dacarbazine in patients with metastatic melanoma
• Radiation therapy in treating patients with head and neck cancer
• Non-psychotic uses for anti-psychotics
  by Aparche Yang
• The revolutionary field of chemoprevention
  by Walter K. Nahm
• NDA filed by Genta for Genasense in the treatment of melanoma
• Screening patients for NCI protocol eligibility
• Celecoxib in preventing basal cell carcinoma in patients with basal cell nevus syndrome
• A letter from the editor-in-chief
  by Perry Robins
• Rationale for the use of topical corticosteroids in melasma
  by Alan Menter
• A novel targeted T-cell modulator, efalizumab, for plaque psoriasis
• Induction of suction blisters in patients with urticaria, blistering diseases, inflammatory dermatoses and neoplastic disorders, and in normal volunteers
• National registry for ichthyosis and related disorders